Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-25 @ 8:15 PM
Study NCT ID:
NCT00660660
Status:
COMPLETED
Last Update Posted:
2015-03-02
First Post:
2008-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9612L00122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None